Teva Initiates Phase III Study To Confirm Increased Efficacy Of Higher Dose Of Glatiramer Acetate For Relapsing-Remitting Multiple Sclerosis
Mon, 07 Aug 2006 06:00 AM EST
... Teva Pharmaceutical Industries Ltd. [click link for full article] ...
Related Topics
- Naltrexone
- Multiple Sclerosis/ms
- Multiple Sclerosis
- Tuberous Sclerosis
- Multiple Myeloma
- Myeloma, Multiple
- Antithrombin III
- Myeloma
- Lichen Sclerosis
- Multiple Chemical Sensitivity
- Familial Dysautonomia
- Education
- Endometriosis
- Fludrocortisone Acetate
- Prolactin
- Interferon Beta-1a Injection (Rebif
- Methylprednisolone
- Twins, Triplets, Multiple Births
- Interferon Beta-1a Injection (Avonex
- Antagon Injection

Not Signed In -


